Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Pharmaceutical Sales by Year
Pharmaceutical Sales — Asia Pacific (other than China and Japan) ($M) ($M)
Merck Pharmaceutical Sales: $2,323M in FY2025, down 5.5% from a year earlier.
Where the FY2025 figure comes from
“|| Asia Pacific (other than China and Japan) | 569 | 636 | 1,205 | 535 | 609 | 1,144 | 593 | 586 | 2,323 | 5 | 5”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Supplemental Table 3c / 3b (Pharmaceutical Geographic Sales).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmaceutical Sales — Asia Pacific (other than China and Japan) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,323 | -5.5% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 2,457 | -7.7% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 2,661 | -12.3% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 3,034 | +67.0% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 1,817 | +12.6% | Form 8-K (tm235007d1_ex99-1.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 1,614 | -35.4% | Form 8-K (tm2131077d1_ex99-1.htm, filed 2021-10-28) ↗ |
| FY2019 | Dec 31, 2019 | 2,500 | – | Form 8-K (tm2032785d1_ex99-1.htm, filed 2020-10-27) ↗ |
Breakdown
What makes up pharmaceutical Sales
Cite this data
StockData. (2026). Merck Pharmaceutical Sales ($M), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/pharma-geo-asiapacific-excnjp
See every metric in the Merck KPI table. Data updated Oct 26, 2026.